Search
Searching Content indexed under Antitrust, EU Competition by Smart & Biggar ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Competition Bureau Publishes Final Updated Intellectual Property Enforcement Guidelines
On March 13, 2019, the Competition Bureau ("Bureau") published the final version of its updated Intellectual Property Enforcement Guidelines (IPEGs).
Canada
15 Apr 2019
2
Agreement Reached Between Competition Bureau And Metro On Quebec Pharmacy Competition Issues
On April 23, 2018, the Competition Bureau announced an agreement whereby Metro will sell properties/leases and take steps to terminate agreements relating to pharmacies in certain Quebec markets.
Canada
25 May 2018
3
The Competition Bureau Applies Strict Standards To Retail Price Claims In Canada
Regular prices, sale prices, clearance sales – these terms are ubiquitous in the retail world and are a familiar component of marketing strategies intended to convince consumers that now is the best...
Canada
15 Mar 2017
4
RxIP Update - 2016 Year In Review
The following are highlights of developments in Canadian life sciences intellectual property and regulatory law in 2016, updating our 2016 mid-year highlights.
Canada
11 Jan 2017
5
Competition Tribunal Weighs ‘Abuse Of Dominant Position' Provision Against Privacy And Copyright Protection
The role of the Competition Act is to maintain and encourage competition in Canada, in part to ensure that small and medium-sized enterprises have the opportunity to participate in the Canadian economy and to provide consumers with competitive prices and choices.
Canada
1 Nov 2016
6
Competition Bureau Releases Draft Update Of Intellectual Property Enforcement Guidelines
On April 2, 2014, the Competition Bureau ("Bureau") released a draft update of its Intellectual Property Enforcement Guidelines ("IPEGs"), which sets out the Bureau's views concerning the manner in which the provisions of the Competition Act would be applied to conduct involving intellectual property rights.
Canada
9 Apr 2014
7
Federal Court Finds PLAVIX Patent Invalid
On December 6, 2011, Justice Boivin of the Federal Court held that Apotex infringed the patent that claims clopidrogel bisulfate (sanofi-aventis's PLAVIX) but that the patent was invalid: "Apotex Inc. v. sanofi-aventis" 2011 FC 1486, appeal pending.
Canada
17 Jan 2012
Links to Result pages
 
1